• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71992-01
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Pain (1994); Skin Irritation (2076)
Event Date 09/22/2020
Event Type  Injury  
Manufacturer Narrative
At this time product has not yet been returned.An extended investigation has been performed for the reported complaint.There was no indication that the product did not meet specification.The reported complaint is related to discomfort/pain/bruising, skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dhrs (device history review) for the freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor kit passed all tests prior to release.Dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
A customer experiencing a skin reaction while wearing the adc freestyle libre 2 sensor, with a symptom of pain and purple at the sensor insertion site.The customer had contact with a healthcare provider who removed the sensor and applied betadine (disinfectant) and prescribed an unspecified ointment as treatment.There was no report of death or permanent injury associated with this event.
 
Event Description
A customer experiencing a skin reaction while wearing the adc freestyle libre 2 sensor, with a symptom of pain and purple at the sensor insertion site.The customer had contact with a healthcare provider who removed the sensor and applied betadine (disinfectant) and prescribed an unspecified ointment as treatment.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
Section d3 (email) and section g1 were updated to reflect current contact information.Sensor ((b)(6)) has been returned and investigated.Visual inspection was performed on the returned sensor and adhesive and no issues were observed.The sensor plug was properly seated in the mount.The sensor plug was removed and the plug assembly was inspected, no issues observed.Further investigation was unable to be performed, as the applicator and and pack were not returned.No malfunction or product deficiency was identified.All pertinent information available to abbott diabetes care has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key10600429
MDR Text Key208974685
Report Number2954323-2020-06656
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 02/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/31/2021
Device Model Number71992-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/16/2020
Initial Date Manufacturer Received 09/22/2020
Initial Date FDA Received09/29/2020
Supplement Dates Manufacturer Received01/26/2021
Supplement Dates FDA Received02/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient Weight94
-
-